Latest News & Features
Americas
As securing patent eligibility for ‘healthcare IT’ applications seems to be becoming easier, companies looking to monetise IP in this area can breathe a sigh of relief. Stacy Taylor of DLA Piper explains more. 23 February 2017
Biotechnology
European Council members exchanged views on IP at the Competitiveness Council this week, agreeing that IP is one of the drivers of productivity and economic growth for companies. 22 February 2017
Americas
The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement. 22 February 2017
Americas
The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case. 22 February 2017
Asia
Danish biotechnology company Novozymes has won a patent dispute against China-based enzyme makers Shandong Longda Bio-Products and Jiangsu Boli Bioproducts at the Supreme People’s Court of China. 21 February 2017
Americas
The US Department of Justice has asked for an injunction to stop a Louisiana-based drug and dietary supplement manufacturer from distributing misbranded and unapproved new drugs and dietary supplements. 21 February 2017
Americas
Anyone drafting patent licence agreements should follow several tips in order to avoid or better prepare for litigation later on, says Jessamyn Berniker of Williams & Connolly. 21 February 2017
Americas
A scientist in Kansas has been convicted for conspiring to steal samples of genetically engineered rice seeds from a US biopharmaceutical research facility, Ventria Bioscience. 20 February 2017
Americas
Novartis has finalised its agreement with biopharmaceutical company Ionis Pharmaceuticals and its wholly-owned subsidiary Akcea Therapeutics to develop and commercialise therapies for cardiovascular disorders. 20 February 2017
Americas
Although the Patent Trial and Appeal Board gave a win to The Broad Institute of Harvard and MIT in the CRISPR patent conflict against the University of California, Berkeley and the University of Vienna, lawyers say the dispute may still not be resolved. 17 February 2017